Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Immunomedics (IMMU)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for IMMU as compared to
Top Competitors
Diagnostic Substances
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
64.1M
AVG
EBITDA
►
-26.9M
LOW
Net Income
►
36.5M
HIGH
Revenue Growth
►
725.4%
VERY HIGH
Operating Margin
►
58.3%
HIGH
Net Margin
►
56.9%
HIGH
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.393
AVG
Current Ratio
►
1.97
LOW
Quick Ratio
►
1.94
AVG
Interest Coverage Ratio
►
197
HIGH
Book Value Per Share
►
0.472
Cash Per Share
►
0.274
Loading...
STOCK SUMMARY
Open
3.20
Day Range
3.05
-
3.40
52 Week Range
0.84
-
7.16
Volume
3.13M
Avg Volume (3 mo)
1.30M
Shares Outstanding
70.5M
Market Cap
233M
VALUATION
Price to Earnings (P/E)
►
7.11
LOW
Price to Book (P/B)
►
7.52
HIGH
Price to Sales (P/S)
►
4.05
AVG
Return on Assets (ROA)
►
62%
VERY HIGH
Return on Equity (ROE)
►
227.6%
HIGH
EV/EBITDA
►
-10.4
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
13.2%
Held by insiders
0.7%
Held by institutions
20.5%
No Sales Breakout Data.